Health / Outside Canada · Evidence review

COVID hospital deaths: examining the Reel’s claims about the NHS and remdesivir

Hospital failures and treatment harms deserve scrutiny. A source review separates the Reel’s allegations from official inquiry findings, an Ebola trial and COVID-19 treatment evidence.

By PBC News Desk · October 14, 2026

A circulating Instagram compilation asks whether COVID deaths were actually murder. It introduces an alleged NHS euthanasia order, features a nurse condemning hospital protocols, and ends with claims about rapid cancers and remdesivir’s ‘53% mortality’. These are serious allegations. They need more than a montage to establish them.

The evidence does support demanding answers about overwhelmed hospitals, isolation, delayed care and treatment risks. It does not support reading an Ebola-trial death rate as proof that remdesivir killed half of COVID patients, or treating deaths in hospitals as proof of a deliberate killing programme.

First, separate the compilation’s sources

The opening narrator says an NHS whistleblower was ordered to euthanize patients in empty hospitals to inflate COVID deaths. The subsequent speaker is Kimberly Overton: her words match the recording Truth Tour San Diego: Kimberly Overton, uploaded by Renegade Media TV on July 1, 2023. The matching passages include her critical-care background, leaving the bedside and the later hospital/ventilator comparisons. This is Truth Tour speech footage, not an NHS hearing. The original event date was not independently established. [10] The supplied extract does not present an NHS employment record, a named hospital, the purported order, patient records or a finding by an investigator. Placing that introduction before a nurse’s speech does not establish that she is the NHS whistleblower described. [1]

The final interview excerpt is another source layer. Its original recording date and complete interview were not established in this review. The September 2026 Instagram repost date should not be mistaken for the dates of the underlying statements. The uploader’s caption adds a depopulation interpretation; that is a claim, not corroborating evidence.

The longer recording also preserves a qualification omitted from this compilation: shortly after the vaccine-harm passage, at approximately 3:19, Overton says that an adverse-event report ‘does not necessarily mean causation’. That distinction matters when presenting her views fairly. The first five minutes were recovered and transcribed to check the source; this review does not verify every claim in the longer speech. [10]

‘They’re not dying at home’: the official record says otherwise

England and Wales recorded 3,221 deaths due to COVID-19 in private homes in 2020, according to the Office for National Statistics. Those deaths accounted for 4.4% of deaths for which COVID-19 was the underlying cause that year. That directly contradicts the compilation’s blanket assertion that patients were not dying at home. These are registered deaths in England and Wales, not a worldwide count or a patient-by-patient audit. [2]

ONS also documented a substantial increase in deaths at home from other conditions and discussed disrupted services and changes in where people received care. Those concerns matter. A hospital’s concentration of very sick patients does not, by itself, establish that treatment caused their deaths.

Hospital failures are not imaginary

The UK Covid-19 Inquiry’s March 19, 2026 healthcare report provides a stronger starting point for accountability than the Reel’s introductory assertion. Its official summary says healthcare systems came close to collapse, that some patients received lower levels of care, and that non-COVID diagnosis and treatment were delayed. It records flawed initial infection-control guidance, inadequate protective equipment and visiting restrictions that left some patients without essential support and some people dying alone. [3]

These are documented failures and harms. They are not the same finding as an order to euthanize patients to increase a death count. PBC did not obtain evidence establishing that order. Nor does this review rule out every instance of negligent or inappropriate care: individual cases require individual records and investigation.

Where the ‘53%’ remdesivir number actually comes from

The trial enrolled patients from November 20, 2018 to August 9, 2019 and was published in 2019. Calling the completed result a known ‘2018’ mortality finding compresses that chronology. The comparison group receiving ZMapp had 84 deaths among 169 patients, or 49.7%. Two antibody-treatment groups performed better, and random assignment to remdesivir and ZMapp was stopped following the interim analysis.

This is a legitimate negative result for remdesivir compared with the better-performing Ebola treatments. But ‘53.1% died in that treatment group’ does not mean ‘the drug caused 53.1% to die’. The trial involved a highly lethal infection and did not measure a COVID drug-caused death rate. The paper also records a remdesivir recipient’s hypotension followed by cardiac arrest as possibly drug-related, while noting that such deaths could not readily be distinguished from fulminant Ebola. Taking safety concerns seriously does not require misrepresenting the denominator. [4]

What COVID evidence can—and cannot—tell us

In the randomized, placebo-controlled ACTT-1 trial of hospitalized adults with COVID-19, median recovery was 10 days with remdesivir versus 15 with placebo. The day-29 mortality estimates were 11.4% versus 15.2%, but the mortality hazard ratio’s confidence interval crossed 1, so that result alone did not establish a clear mortality reduction. The study supported faster recovery in its studied population, not universal benefit in every disease stage or proof that harm is impossible. [5]

The FDA approved remdesivir on October 22, 2020 after an earlier emergency authorization. Its announcement called it the first approved COVID-19 treatment—not an unrestricted ‘drug of choice’ for everyone. [6] The prescribing information lists real risks, including serious hypersensitivity/infusion reactions and increased liver enzymes, and requires clinical monitoring. Approval does not erase those risks. [7]

Similarly, calling ventilators ‘gas chambers’ is a rhetorical comparison, not clinical evidence. Establishing avoidable harm would require examination of the indication for ventilation, settings, medication and sedation records, consent, timing and the patient’s underlying illness. A poor outcome is not, on its own, proof of malicious intent.

Rapid-cancer claims need a traceable study

The final speaker says rapid cancers were known in advance, but the supplied excerpt does not identify a paper that demonstrates that allegation. The U.S. National Cancer Institute’s patient guidance states there is no evidence that COVID-19 vaccines cause cancer, recurrence or disease progression. That is the institute’s evidence assessment—not a claim that every future hypothesis is impossible, and not a substitute for investigating a patient’s symptoms. [8]

Recognized vaccine harms should not be brushed aside. Canada’s official safety guidance acknowledges rare serious reactions, including myocarditis and pericarditis. Those recognized adverse effects do not themselves establish a rapid-cancer mechanism or a deliberate depopulation programme. [9]

What would move the allegations beyond a Reel?

• The full original statements, dates, locations and verified professional roles—not just edited extracts.
• The alleged written order and the hospital or authority responsible for it.
• Lawfully obtained, appropriately redacted patient records, medication charts, ventilation logs and consent documentation.
• Independent clinical review, and any relevant regulator, coroner or court findings.
• For a cancer claim, an identifiable study with an appropriate comparison group, a defined outcome and follow-up adequate to test causation.

Bottom line: scrutiny of pandemic care is justified. The official record already documents serious failures. This compilation, however, does not prove an NHS euthanasia order, a 53% remdesivir-caused COVID death rate or an intentional mass-killing programme. Accountability is strengthened—not weakened—by keeping those distinctions clear.

Related PBC coverage: Kimberly Overton’s hospital-protocol allegations and the separate payment/treatment evidence.